Moderna, Inc. Free Cash Flow 2016–2025
Moderna, Inc. reported $-2.06B of free cash flow for fiscal 2025. That was 49.1% higher than fiscal 2024. Compared with fiscal 2020, the change was -205.4%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $-2.06B | +49.1% |
| FY 2024 | $-4.05B | -6.0% |
| FY 2023 | $-3.83B | -183.5% |
| FY 2022 | $4.58B | -65.6% |
| FY 2021 | $13.34B | +580.8% |
| FY 2020 | $1.96B | +499.0% |
| FY 2019 | $-491.00M | -12.5% |
| FY 2018 | $-436.63M | -12.0% |
| FY 2017 | $-389.88M | -1260.7% |
| FY 2016 | $33.59M | — |
Source: Moderna, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open MRNA 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Moderna, Inc. reported $-2.06B of free cash flow for fiscal 2025. That was 49.1% higher than fiscal 2024. Compared with fiscal 2020, the change was -205.4%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Moderna, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeModerna, Inc. — frequently asked questions
What is Moderna, Inc.'s free cash flow?
Moderna, Inc. (MRNA) reported free cash flow of $-2.06B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Moderna, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.